Professional News Update 9/7/2006
David Maxwell (Yale, Ph.D.) recently attended the Society for Molecular Imaging meeting in Hawaii, where he was author/co-author of several posters ranging in subject from the in-silico design of thymidine kinase substrates to the analysis of spheroids. He is currently working on the design of several kinase inhibitors as part of the Leukemia SPORE project, and the success towards a c-Kit compound was recently described at the 14th Annual SPORE Investigators’ Workshop in Baltimore, MD.
Steven Wesolowski (Yale, Postdoc) was promoted to Senior Scientist at AstraZeneca Pharmaceuticals this year. He has also taken on the position of Group Leader, and as such, oversees the research of several Ph.D. -level computational chemists.
